A Phase II Trial of Avelumab in Patients With Recurrent or Progressive Osteosarcoma

NCT03006848 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Osteosarcoma

Interventions

DRUG: Avelumab
OTHER: Questionnaires

Sponsor

St. Jude Children's Research Hospital

Collaborators

[object Object]
[object Object]